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BACKGROUND

THEORETICAL MODEL

Sustainability in the healthcare industry has become
paramount as technology advances and the financial,
environmental, and social benefits become more well known.
In 1993, the Medical Device Directive (MDD) was developed,
which allowed safe reuse and reprocessing of single-use
medical devices, by creating standards and regulations for
device manufacturers. However, this type of policy does not
exist worldwide. India lacks policy and regulation over safe
reuse and reprocessing of medical devices.

Two components of the Integrated Acceptance and
Sustainability Assessment Model (IASAM) were applied
(acceptance and management) to evaluate policies
regarding reusable medical devices in India and the
United Kingdom.
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RESULTS

PURPOSE
The purpose of this study is to compare the policies of the
United Kingdom (UK) and India regarding reusable medical
devices and explore the environmental and financial outcomes
of implementing a more sustainable approach to medical
devices in India.

METHODS

A comparative policy analysis was conducted using the
Integrated Acceptance and Sustainability Assessment
Model (IASAM) to explore differences between existing
policies regarding reusable medical device in India and the
UK. International precedents were applied to develop
projections estimating the environmental and financial
impact of implementing a sustainable approach in India.
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RESEARCH QUESTIONS
1. How do policies influencing reuse of medical devices in
India and the UK differ?
2. How does the environmental impact and expenditures
related to reuse of medical devices differ between India and
the UK?
3. How would implementation of a more sustainable approach
to medical devices impact the environment and
expenditures in India?
4. What recommendations can be made to inform policy
makers regarding reusable medical devices in India?

Comparisons of the UK and India based on the components of the IASAM Framework
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The UK and India were found to have similar healthcare system components (government role, insurance opportunities and coverage) based on all
relevant dimensions of the framework.
The major difference was that the UK regulates policies at the governmental level, while India regulates the reprocessing at the hospital level.
India was found to have a greater healthcare expenditure compared to the UK, but the expenditures per capita were much lower for India.
India has increased in their CO2 emissions from manufacturing, the indicator used to measure environmental impact, while the UK had reduced their
emissions since 1993, the implementation of the MDD.

RECOMMENDATIONS
• Adapt MDD and other global policies existing regarding medical device
reprocessing
• Integrate labeling system of MDD and standard process for
remanufacturers to follow when reprocessing
• Allow hospitals to be accountable for reprocessing
• Create organization or committee for each hospital to oversee
processes
• Create standardized lowered prices for reprocessed devices
• Increase government spending to mimic the UK healthcare system and
increase per capita expenditure
• Insurance coverage over reprocessed medical device

PROPOSED IMPACT

• Increase in generation of jobs by 20%
• 60-70% reduction in device prices resulting in 382
crore turnover ($61.12 million cost savings) for India
• 20% reduction in waste generated
• 10% reduction in CO2 emissions
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